
Home » Prescription Drugs 5 » Coversyl Coversyl Plus
Product Origin: EU (Turkey) This product is able to be sourced and supplied at excellent prices because of favourable cross border currency conversions. All products are authentic brand names and will include a product information insert in English. Medical Information: Coversyl Tablets is indicated in patients with stable coronary artery disease to reduce the risk of cardiovascular mortality or nonfatal myocardial Infarction. Coversyl Tablets can be used with conventional treatment for management of coronary artery disease such as antiplatelet antihypertensive or lipid lowering therapy. Hypertension: Coversyl Tablets is indicated for the treatment of patients with essential hypertension. Coversyl Tablets may be used alone or given with other classes of antihypertensives especially thiazide diuretics.
Buy Coversyl Coversyl Plus and other Prescription Drugs 5 products online
at Medstore.
Buy Online at Medstore - Click Here!

About Coversyl Coversyl Plus:
Product Type: Prescription Drugs 5
Coversyl Plus ( Corversyl Aceon Generic Perindopril & Indapamide )
Coversyl (Coversyl Plus Aceon Generic Perindopril)
Coversyl Plus Aceon Generic Perindopril
5mg 30 Tablets 8mg 90(3 x 30) Tablets 4mg
Coversyl Plus Aceon Generic Perindopril Coversyl

View more
Prescription Drugs 5
Previous Product Next Product
Pharmacy:
Dozens of patents for name-brand drugs are due to expire within the next 14 months, and generic drugs will replace some of the most popular and widely advertised drugs used today. For millions of people worldwide, this means switching from familiar brands like Lipitor to generic equivalents. How will this affect drug companies, and what will be the impact on people who depend on expensive prescription medication? Here, a brief guide:
Which drugs are scheduled to go generic?
Some real blockbusters. "In the next two years, six of the 10 top-selling drugs will lose their patents," says Chris Woolston in the Los Angeles Times. Lipitor, the world's best-selling drug, which is used to lower cholesterol, will be available as a generic in November of this year. Another best-seller, the blood thinner Plavix, will lose its patent in May 2012. Other well-known drugs with expiring patents include the arthritis treatment Enbrel, the anti-psychotic Zyprexa, as well as drugs for bipolar disorder, HIV, high cholesterol, and other conditions.


|